Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth

Area of Science:

• Neuro-oncology
• Nanotechnology
• Immunology

Background:

• Brain tumors, particularly glioblastoma (GBM), pose significant clinical challenges due to their invasive nature.
• The central nervous system (CNS) responds to injury by forming astroglial scars that wall off damaged areas.
• Current treatments for invasive brain tumors often have limitations.

Purpose of the Study:

• To test the hypothesis that activating peritumoral cells via an inflammatory stimulus can contain invasive brain tumors.
• To engineer a novel therapeutic approach using targeted nanoparticles to induce a tumor-walling effect.

Main Methods:

• Gold nanoparticles coated with inflammatory polypeptides were engineered to target stromal cells near glioblastoma (GBM) tumors.
• The nanoparticles were used to stimulate stromal CNS inflammation in rodent models of GBM.
• Tumor containment and immune response activation were assessed.

Main Results:

• The engineered nanoparticles significantly contained GBM tumors in rodent models, reducing tumor volume by over 300% compared to controls.
• This containment was associated with the activation of innate and adaptive immune responses.
• Pathways related to cell clustering were triggered, contributing to tumor walling.

Conclusions:

• Targeting peritumoral cells with inflammatory stimuli can create a barrier to contain invasive brain tumors.
• This nanoparticle-based approach shows promise as an adjuvant therapy for glioblastoma (GBM).
• The strategy leverages the brain's natural inflammatory response to combat tumor invasion.